COMPARE · Data as of August 21, 2026
ETOR vs NMR
Verdict: Side-by-side breakdown using the Bull Rankings model. ETOR scored 82.0, NMR scored 69.0 — ETOR leads.
Compare another set
ETOR
eToro Group Ltd.
64Fin
$30.31 · $2.4B
fundamentals as of
Strength gap
5.0
NMR leads
NMR
Nomura Holdings, Inc.
69Fin
$9.72 · $28.4B
At a glance · who leads each dimension, on the model's own rules
- CheapestETOR10.9x
- Fastest growthNMR+10.8%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
Fundamentals, head-to-head
ETOR
NMR
+9.4%B
Rev
+10.8%B
10.9xA-
P/E
11.6xB+
19.5%B+
ROE
11.2%B
1.78B
P/B
1.15B+
0.0%C
Yield
3.4%B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
ETOReToro Group Ltd.
Why now
Capital Markets · market cap $2.4b. Down 36% from 52-week high of $47.70 — deep drawdown territory. PEG 0.55 — paying under fair value for the growth rate. 14 sell-side analysts rate this a Buy with a mean 1-yr target of $48.43 (implying +60% upside).
Moat
ROE 19% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
Down 36% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Net margin 2.2% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. Regulatory capital risk — stricter capital requirements (CCAR, Basel) can force a dividend cut or a capital raise; the largest banks are most exposed because they're held to the tightest standards.
NMRNomura Holdings, Inc.
Why now
Capital Markets · market cap $28.4b. 3% off the 52-week high of $10.06. Revenue growing +11%, comfortably above the S&P median. PEG 0.81 — paying under fair value for the growth rate.
Moat
Net margin 17% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 11% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
D/E 9.46 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.